[ Price : $8.95]
FDA grants Theriva Biologics a fast-track designation for its lead clinical candidate VCN-01 in combination with gemcitabine and n...[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America asks FDA to address four issues relating to implementation of the FDA Reautho...[ Price : $8.95]
Vyaire Medical recalls (Class 1) its Twin Tube sample lines, which are used on the Vyntus CPX Cardiopulmonary Exercise Test, due t...[ Price : $8.95]
Federal Register notice: FDA makes available a draft revised guidance entitled Studies to Evaluate the Safety of Residues of Veter...[ Price : $8.95]
FDA approves a CorTec IDE to allow the University of Washington School of Medicine to conduct a study involving the closed-loop Br...[ Price : $8.95]
Federal Register notice: FDA extends the comment period on its proposed rule entitled Labeling Requirements for Approved or Condit...[ Price : $8.95]
Based on disappointing Phase 3 trial data, Otsuka Pharmaceutical terminates its development of the novel compound AVP-786 as a pot...[ Price : $8.95]
FDA asks an advisory panel to vote on the safety and effectiveness of the Guardant Shield colorectal screening test for use with p...